Skip to content
10-Q

Quarterly Report

ENTASIS THERAPEUTICS HOLDINGS INC.

0001558370-21-011391

← back to feed
Filed
Aug 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 9, 2021 47.31M sh
Capex Q2 2021 · Jun 30, 2021 $33K
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$18.58M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$24.56M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $56.41M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $53.25M
Stockholders Equity Q2 2021 · Jun 30, 2021 $53.06M
Stockholders Equity Q2 2021 · Mar 31, 2021 $44.26M
Stockholders Equity Q2 2021 · Dec 31, 2020 $52.29M
Stockholders Equity Q2 2021 · Jun 30, 2020 $49.29M
Stockholders Equity Q2 2021 · Mar 31, 2020 $27.7M
Stockholders Equity Q2 2021 · Dec 31, 2019 $42.16M
Current Liabilities Q2 2021 · Jun 30, 2021 $10.14M
Current Liabilities Q2 2021 · Dec 31, 2020 $8.57M
Total Liabilities Q2 2021 · Jun 30, 2021 $10.51M
Total Liabilities Q2 2021 · Dec 31, 2020 $9.27M
Current Assets Q2 2021 · Jun 30, 2021 $62.42M
Current Assets Q2 2021 · Dec 31, 2020 $60.13M
Total Assets Q2 2021 · Jun 30, 2021 $63.57M
Total Assets Q2 2021 · Dec 31, 2020 $61.56M
Sga Expense Q2 2021 · Jun 30, 2021 $3.31M
Sga Expense Q2 2021 · Jun 30, 2021 $6.62M
Sga Expense Q2 2021 · Jun 30, 2020 $3.24M
Sga Expense Q2 2021 · Jun 30, 2020 $7.02M
Rd Expense Q2 2021 · Jun 30, 2021 $9.99M
Rd Expense Q2 2021 · Jun 30, 2021 $19.36M
Rd Expense Q2 2021 · Jun 30, 2020 $10.24M
Rd Expense Q2 2021 · Jun 30, 2020 $21.86M
Net Income Q2 2021 · Jun 30, 2021 −$12.03M
Net Income Q2 2021 · Jun 30, 2021 −$22.73M
Net Income Q2 2021 · Jun 30, 2020 −$13.4M
Net Income Q2 2021 · Jun 30, 2020 −$28.66M
Operating Income Q2 2021 · Jun 30, 2021 −$13.3M
Operating Income Q2 2021 · Jun 30, 2021 −$25.97M
Operating Income Q2 2021 · Jun 30, 2020 −$13.48M
Operating Income Q2 2021 · Jun 30, 2020 −$28.88M